Adaptive Biotechnologies Corporation
ADPT | NASDAQ
$27.70
-$0.16 (-0.57%)
Sep 22, 2026, 12:00 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 276.98M | 178.96M | 170.28M | 185.31M | 154.34M | 98.38M |
Cost of Revenue | 71.36M | 72.08M | 75.55M | 57.91M | 49.3M | 22.53M |
Gross Profit | 205.62M | 106.88M | 94.72M | 127.4M | 105.04M | 75.85M |
Operating Income | -57.12M | -162.55M | -227.04M | -200.19M | -208.97M | -152.82M |
Interest Income | 9.44M | 14.53M | 15.53M | 4.06M | 1.67M | 6.59M |
Pretax Income | -59.46M | -159.6M | -225.3M | -200.37M | -207.3M | -146.23M |
Net Income | -59.5M | -159.49M | -225.25M | -200.19M | -207.28M | -146.23M |
Selling & General & Admin | 167.27M | 157.57M | 172.51M | 184.13M | 169.97M | 110.89M |
Research & Development | 93.77M | 102.95M | 122.12M | 141.76M | 142.34M | 116.07M |
Other Expenses | 1.7M | 8.91M | 27.13M | 1.7M | 1.7M | 1.7M |
Operating Expenses | 262.74M | 269.43M | 321.76M | 327.59M | 314.01M | 228.67M |
Interest Expense | 11.78M | 11.58M | 13.8M | 4.24M | n/a | n/a |
Selling & Marketing Expenses | 94.57M | 84.76M | 88.58M | 95.6M | 95.47M | 61.36M |
Cost & Expenses | 334.1M | 341.51M | 397.31M | 385.49M | 363.31M | 251.2M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 151.72M | 147.1M | 144.38M | 142.52M | 140.35M | 131.22M |
Shares Outstanding (Diluted) | 151.72M | 147.1M | 144.38M | 142.52M | 140.35M | 131.22M |
EPS (Basic) | -0.39 | -1.08 | -1.56 | -1 | -1.46 | -1.06 |
EPS (Diluted) | -0.39 | -1.08 | -1.56 | -1 | -1.46 | -1.06 |
EBITDA | -29.85M | -128.76M | -189.27M | -175.21M | -193.35M | -144.35M |
EBIT | -47.68M | -148.02M | -211.5M | -196.13M | -207.3M | -152.82M |
Depreciation & Amortization | 17.83M | 19.26M | 22.23M | 20.92M | 13.95M | 8.47M |
Add to Watchlist
Select watchlists to add or remove ADPT